Details

<p>Editors Volume 1 xi</p> <p><b>Volume 2: Neoplastic Hematology & Cellular Therapy</b></p> <p>Editors xii</p> <p>Editor's Biography xiii</p> <p>Preface xv</p> <p>Acknowledgment xvii</p> <p><b>Part 1 Central Nervous System 1</b></p> <p>1 Central Nervous System Tumors 3<br /><i>Mark R. Gilbert and Edina Komlodi-Pasztor</i></p> <p><b>Part 2 Head and Neck and Thoracic Cancers 13</b></p> <p>2 Localized Head and Neck Cancer 15<br /><i>Emrullah Yilmaz and Jessica L. Geiger</i></p> <p>3 Recurrent and Metastatic Head and Neck Cancer 31<br /><i>Chloe Weidenbaum and Mike Gibson</i></p> <p>4 Thyroid Cancers 39<br /><i>Kartik Sehgal and Jochen H. Lorch</i></p> <p>5 Non-Small Cell Lung Cancer: Screening, Staging, and Stage I 51<br /><i>Ryan D. Gentzler and Linda W. Martin</i></p> <p>6 Non-Small Cell Lung Cancer: Stages II and III 63<br /><i>Gregory Peter Kalemkerian, Kamya Sankar, and Angel Qin</i></p> <p>7 Recurrent and Metastatic Non-Small Cell Lung Cancer 79<br /><i>Julia Judd, J. Nicholas Bodor, and Hossein Borghaei</i></p> <p>8 Small Cell Lung Cancer 97<br /><i>Jyoti D. Patel and Husam Hafzah</i></p> <p>9 Mesothelioma 105<br /><i>Harvey I. Pass, David Chen, and Jack Donaghue</i></p> <p><b>Part 3 Breast Cancer 115</b></p> <p>10 DCIS and LCIS 117<br /><i>Amanda Nash, Rita Mukhtar, and Shelley Hwang</i></p> <p>11 Early-Stage ER/PR –Positive, HER2-Negative Breast Cancer 129<br /><i>William J. Gradishar</i></p> <p>12 ER/PR-Positive, HER2-Negative Metastatic Breast Cancer 139<br /><i>Sara Nunnery, Laura Kennedy, and Sonya Reid</i></p> <p>13 Early-Stage HER2-Positive Breast Cancer 151<br /><i>Erin Roesch and Jame Abraham</i></p> <p>14 HER2-Positive Metastatic Breast Cancer 163<br /><i>Reshma L. Mahtani, Naomi G. Dempsey, and Ana Sandoval</i></p> <p>15 Early-Stage Triple-Negative Breast Cancer 179<br /><i>Tiffany A. Traina, Carlos dos Anjos, and Elaine Walsh</i></p> <p>16 Triple-Negative Metastatic Breast Cancer 191<br /><i>Azadeh Nasrazadani, Juan Gomez, and Adam Brufsky</i></p> <p>17 Inflammatory Breast Cancer – A Distinct Entity 201<br /><i>Massimo Cristofanilli and Elena Vagia</i></p> <p>18 Male Breast Cancer 213<br /><i>Laura A. Huppert, Ozge Gumusay, Shreya Desai, and Hope S. Rugo</i></p> <p>19 Breast Cancer in Pregnancy and Fertility Preservation 225<br /><i>Fedro A. Peccatori, Hatem Azim, and Matteo Lambertini</i></p> <p><b>Part 4 Gastrointestinal Cancers 233</b></p> <p>20 Early-Stage Gastroesophageal Cancer and Precursor Lesions 235<br /><i>Yixing Jiang and Aaron Ciner</i></p> <p>21 Metastatic Esophagogastric Cancer 249<br /><i>Geoffrey Y. Ku and David H. Ilson</i></p> <p>22 Early-Stage Colon Cancer 255<br /><i>John Krauss, Vaibhav Sahai, and Al B. Benson III</i></p> <p>23 Early-Stage Rectal Cancer 267<br /><i>Hannah J. Roberts, Theodore Hong, and Aparna Parikh</i></p> <p>24 Recurrent and Metastatic Colorectal Cancer 283<br /><i>Joseph Heng and Blase Polite</i></p> <p>25 Pancreatic Adenocarcinoma 291<br /><i>Evan Walker, Andrew Ko, and Margaret Tempero</i></p> <p>26 Hepatocellular Cancer 309<br /><i>Pedro Luiz Serrano Uson Junior and Mitesh Borad</i></p> <p>27 Biliary Tract Cancers 319<br /><i>David B. Zhen and Vaibhav Sahai</i></p> 28 Carcinoid and Neuroendocrine Tumors 327<br /><i>Mintallah Haider and Jonathan Strosberg</i> <p>29 Anal Cancer 343<br /><i>Asad Mahmood and Rob Glynne-Jones</i></p> <p><b>Part 5 Genitourinary Cancers 359</b></p> <p>30 Renal Cancer 361<br /><i>James L. Coggan, Alan Tan, and Timothy M. Kuzel</i></p> <p>31 Bladder Cancer 375<br /><i>Revathi Kollipara, Alan Tan, and Timothy M. Kuzel</i></p> <p>32 Prostate Cancer: Screening, Surveillance, Prognostic Algorithms, and Independent Pathologic Predictive Parameters 389<br /><i>Eduardo Benzi and Thomas M. Wheeler</i></p> <p>33 Early and Locally Advanced Prostate Cancer 399<br /><i>James Randall, Mohammad R. Siddiqui, Ashley Ross, and Sean Sachdev</i></p> <p>34 Metastatic Prostate Cancer 421<br /><i>Priyanka Chablani, Natalie Reizine, and Walter Stadler</i></p> <p>35 Germ Cell Tumors 437<br /><i>Hamid Emamekhoo, Syed A. Abutalib, and Timothy Gilligan</i></p> <p><b>Part 6 Skin Malignancies 453</b></p> <p>36 Melanoma 455<br /><i>Ana M. Ciurea and Kim Margolin</i></p> <p>37 Nonmelanoma Skin Cancers 477<br /><i>Chrysalyne D. Schmults and Danielle A. Parker</i></p> <p><b>Part 7 Gynecological Cancers 497</b></p> <p>38 Ovarian Cancer: Primary Treatment and Approach to Recurrent Disease 499<br /><i>Rani Bansal, Don Dizon, and Martina Murphy</i></p> <p>39 Ovarian Cancer: Second-line Treatment Strategies 511<br /><i>Maurie Markman</i></p> <p>40 Endometrial Cancer 523<br /><i>Maurie Markman</i></p> <p>41 Cancer of the Cervix, Vulva, and Vagina 533<br /><i>Sabrina M. Bedell and Peter G. Rose</i></p> <p>42 Uncommon Gynecologic Cancers 549<br /><i>Michael Frumovitz, Shannon Westin, and David M. Gershenson</i></p> <p><b>Part 8 Sarcomas 565</b></p> <p>43 Bone Sarcomas 567<br /><i>Nicole Larrier, William Eward, and Richard F. Riedel</i></p> <p>44 Soft Tissue Sarcomas 579<br /><i>Jeffrey Farma, Krisha Howell, and Margaret von Mehren</i></p> <p><b>Part 9 Hereditary Cancer Syndromes and Genetic Testing 595</b></p> <p>45 Hereditary Cancer Syndromes 597<br /><i>Mary B. Daly</i></p> <p>46 Hereditary Breast and Ovarian Cancer Syndromes 611<br /><i>Kristen Whitaker and Elias Obeid</i></p> <p>47 Hereditary Gastrointestinal and Pancreatic Cancer Syndromes 625<br /><i>Kristen M. Shannon, Linda H. Rodgers-Fouche, and Daniel C. Chung</i></p> <p><b>Part 10 Special Issues in Oncology 637</b></p> <p>48 Cancer of Unknown Primary 639<br /><i>Tony Greco</i></p> <p>49 Anticoagulation in Cancer 651<br /><i>Jean Marie Connors</i></p> <p>50 Identification and Management of Immunotherapy-Related Adverse Events in Oncology 663<br /><i>Ozge Gumusay, Laura A. Huppert, Dame Idossa, and Hope S. Rugo</i></p> <p>51 Geriatric Oncology 677<br /><i>Sukeshi Patel Arora and Efrat Dotan</i></p> <p>52 Palliative Medicine for Curable and Terminal Cancers 693<br /><i>Isabelle Blanchard, Kavitha Jennifer Ramachandran, and Divya Gupta</i></p> <p>Index 709</p>

<p><b>Syed A. Abutalib, MD,</b> is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP^® Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), Part of City of Hope. <p><b>Maurie Markman, MD,</b> is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope. <p><b>Al B. Benson III, M.D FACP FASCO,</b> is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine in Chicago, Illinois, and the Associate Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center. <p><b>Hope S. Rugo, MD, FASCO,</b> is Director of Breast Oncology and Clinical Trials Education and a Professor of Medicine at the University of California San Francisco Comprehensive Cancer Center.

<p><b>New edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes</b> <p><i>Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, Second Edition</i> includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes: <ul><li>Up-to-date, clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy and translational cancer research</li> <li>Sections on head, neck, thoracic, breast, GI, genitourinary, skin, gynecological and hereditary cancers, amongst other topics</li> <li>Streamlined, engaging content to make finding information easier and less time consuming for the reader</li> <li>Concise and practical expert perspectives that reference key studies</li> <li>References to the latest NCCN, ESMO, ASCO, and other national guidelines</li></ul> <p>With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, <i>Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, Second Edition</i> will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM, hematology and oncology fellowship and recertification exams.

GB